Tema Etfs »

Iovance Biotherapeutics shares owned by Tema Etfs

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Tema Etfs from 13F filings

Historical chart of Tema Etfs investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Tema Etfs consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Tema Etfs

Quarter filed Position value Share count Share price at filing
2025-09-30 $377k 174k 2.17

More positions owned by Tema Etfs

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Eli Lilly & Co. (LLY)
Caterpillar (CAT)
Amazon (AMZN)
Powell Industries (POWL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Visa Com Cl A (V)
Eaton Corp SHS (ETN)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Cognex Corporation (CGNX)
Abbvie (ABBV)

View all positions for Tema Etfs

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors

View all funds holding Iovance Biotherapeutics